Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
116.34
+3.49 (3.09%)
Aug 12, 2026, 12:54 PM EDT - Market open
Rhythm Pharmaceuticals Market Cap
Rhythm Pharmaceuticals has a market cap or net worth of $8.01 billion as of August 12, 2026. Its market cap has increased by 31.11% in one year.
Market Cap
8.01B
Enterprise Value
7.79B
1-Year Change
31.11%
Ranking
Category
Stock Price
$116.34
ChartMarket Cap Chart
Since October 5, 2017, Rhythm Pharmaceuticals's market cap has increased from $813.90M to $8.01B, an increase of 884.14%. That is a compound annual growth rate of 29.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 7.95B | 11.31% |
| Dec 31, 2025 | 7.14B | 107.63% |
| Dec 31, 2024 | 3.44B | 26.64% |
| Dec 29, 2023 | 2.72B | 65.56% |
| Dec 30, 2022 | 1.64B | 227.07% |
| Dec 31, 2021 | 501.70M | -61.82% |
| Dec 31, 2020 | 1.31B | 30.30% |
| Dec 31, 2019 | 1.01B | 9.04% |
| Dec 31, 2018 | 925.00M | 16.66% |
| Dec 29, 2017 | 792.90M | -2.58% |
| Oct 5, 2017 | 813.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 9.56B |
| Ionis Pharmaceuticals | 9.51B |
| Spyre Therapeutics | 9.24B |
| Crinetics Pharmaceuticals | 8.94B |
| Kymera Therapeutics | 8.89B |
| Vaxcyte | 8.74B |
| Immunovant | 8.17B |
| ImmunityBio | 7.90B |